Aragen, a CRDMO, has launched the first phase of its biologics manufacturing facility in Bangalore, India. The $30 million project, executed by its subsidiary Aragen...
Merck is pouring over €300 million into a new Bioprocessing Production Centre in Daejeon, South Korea. This marks the largest investment by Merck's Life Science sector in...
Greentech firm Afyren Neoxy, a subsidiary of Afyren, received a €3.4 million payment this week for achieving key milestones with its bio-based low-carbon products.
Evonik Vland Biotech, a new joint venture between Evonik China and Shandong Vland Biotech, began operations on January 1, 2024. The venture aims to expand the market...
Dive into the forefront of bioprocessing evolution this March, where our expert panel explores sustainability, bioseparations, and innovation in cell and gene therapy...
Epsilogen and Lonza have successfully completed the manufacturing of a potential cancer treatment. The complex process, which took less than ten months, was carried out...
Merck has expanded its Biologics Testing Center in China with 1,500 m2 of new biosafety laboratories. The company is investing a total of €29 million in its testing...
Samsung Biologics, a global contract development and manufacturing organization (CDMO), and Kurma Partners, a European venture capital firm in healthcare and...
